FDA Inspection
Samuel J. Maiser, M.D., Clinical InvestigatorSamuel J. Maiser, M.D., Clinical Investigator – FDA Inspection, Feb 11, 2022
Record Details
This FDA Inspection record concerns Samuel J. Maiser, M.D., Clinical Investigator, with an inspection on February 11, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 11, 2022
- Product Type
- Drugs
View Company Profile
ID · d02f61c9-3e55-4960-97e3-b1d1b3bbb660
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1162087
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.64(b)Safety reports
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.